We are infection control

Dangerous drug resistant superbug now found in New York

back to Overview

Researchers may have identified a second patient harbouring a new drug resistant “superbug” in New York. The bacteria in question is an E. coli containing the mcr-1 colistin resistance gene. Colistin is a last resort antibiotic used for some multidrug-resistant organisms. U.S. Officials fear the transfer of this resistance gene to other multi-drug resistant bacteria, such as Carbapenem-resistant Enterobacteriaceae (CRE), which could result in an infection that is virtually untreatable with antibiotics. This discovery follows the first incidence of an E. coli containing the mcr-1 gene from a patient in Pennsylvania back in May 2016. At that time, Dr. Gail Cassell, a senior lecturer at Harvard Medical School stated “It is dangerous and we would assume it can be spread quickly”. The best method to stem the spread of this bacterium is to use proper cleaning and disinfection procedures, which will become absolutely essential in preventing infections as treatment options decline. Medentech’s US EPA registered hospital disinfectant tablets are highly effective against E. coli and can be used to limit the spread of this superbug.